中医药防治非酒精性脂肪性肝病的作用机制

侯艺鑫; 王宪波; 杨玉英; 江宇泳

doi:10.3969/j.issn.1001-5256.2016.04.041

中医药防治非酒精性脂肪性肝病的作用机制

DOI: 10.3969/j.issn.1001-5256.2016.04.041

首都医科大学附属北京地坛医院

基金项目:

国家自然科学基金(81273743,81473641)；北京市卫生系统高层次人才专项(2013-2-11)；

详细信息

中图分类号: R259
计量
- 文章访问数: 1641
- HTML全文浏览量: 49
- PDF下载量: 421
- 被引次数: 0
出版历程
- 出版日期: 2016-04-20

Action of mechanism of traditional Chinese medicine in prevention and treatment of nonalcoholic fatty liver disease

Beijing Ditan Hospital Affiliated to Capital Medical University

Research funding:

摘要

摘要:
目前对于非酒精性脂肪性肝病(NAFLD)发病机制的研究越来越广泛,中医药在NAFLD中的作用机制成为新的研究热点。中医药治疗NAFLD取得好的临床疗效,且具有针对性及灵活性、多层次、多靶点治疗的优势。介绍了中医药在改善胰岛素、调节脂质代谢、抗脂质过氧化、调节细胞因子、调控脂质代谢相关因子及动态平衡、维持肠道微生态平衡等方面的作用,同时分析了中医药研究目前存在的主要问题。
- 脂肪肝 /
- 中医疗法 /
- 综述
Abstract: In recent years,extensive studies have been conducted on the pathogenesis of nonalcoholic fatty liver disease( NAFLD),and the action of mechanism of traditional Chinese medicine( TCM) in NAFLD has become a new research topic. TCM has achieved good clinical efficacy in the treatment of NAFLD,with the advantages of specific,flexible,multilevel,and multi- target treatment. This article introduces the role of TCM in improving insulin,regulating lipid metabolism,preventing lipid peroxidation,regulating cytokines,regulating and maintaining the dynamic balance of factors involved in lipid metabolism,and maintaining the balance of intestinal microflora,and analyzes the major problems in TCM research.
- fatty liver /
- TCM therapy /
- review

HTML全文

参考文献(33)

[1]CHEN P,GU Q,ZHOU XB,et al.Experimental research on Dan Ning tablet to prevent and cure nonalcoholic fatty liver disease[J].Jilin J Tradit Chin Med,2014,34(4):399-402.(in Chinese)陈鹏,顾勤,周晓波,等.胆宁片防治非酒精性脂肪肝的实验研究[J].吉林中医药,2014,34(4):399-402.

[2]VARELA R,MBAD E,ARIZ U,et al.Nonalcoholic steatohepatitis and animal models:understanding the human disease[J].Int JBiochem Cell Biol,2009,41(5):969-976.

[3]ANGULO P,LINDOR KD.Nonalcoholic fatty liver disease[J].J Gastroenterol Hepatol,2002,17(Supp1):186-190.

[4]DEIVANAYAGAM S,MOHAMMED BS,VITOLA BE,et al.Nonalcoholic fattyliver disease is associated with hepatic and skeletal muscle insulin resistancein overweight adolescents[J].Am J Clin Nutr,2008,88(6):180-189.

[5]WANG WQ,LI YP,SHEN Z,et al.Research on the interference of insulin resistance in nonalcoholic steatohepatitis by qinggantiaozhi decoction[J].J Clin Hepatol,2011,27(5):479-481.(in Chinese)王伟芹,李亚萍,神州,等.清肝调脂饮对非酒精性脂肪性肝炎大鼠胰岛素抵抗的影响[J].临床肝胆病杂志,2011,27(5):479-481.

[6]KAMADA Y,TAKEHARA T,HAYASHI N.Adipocytokines and liver disease[J].J Gastroenterol,2008,43(11):811-822.

[7]ZHENG LY,PAN JQ,YANG YL,et al.Effect of total glucosides of paeony on apelin and visfatin expression in rats with nonalcoholic fatty liver disease[J].Tradit Chin Drug Res Clin Pharmacol,2013,24(1):51-54.(in Chinese)郑琳颖,潘竞锵,杨以琳,等.白芍总苷对非酒精性脂肪性肝病大鼠Apelin和Visfatin表达的影响[J].中药新药与临床药理,2013,24(1):51-54.

[8]YANG WF,QI YP,LI M,et al.Effects of“shenge decoction”on lipidic metabolism of rats with nonalcoholic fatty liver disease induced by high fat diet[J].Acta Univ Tradit Med Sin Pharmacol Shanghai,2012,26(1):63-67.(in Chinese)杨婉凤,齐艳平,李曼,等.参葛方对单纯高脂饮食诱导的非酒精性脂肪性肝病大鼠脂质代谢的影响[J].上海中医药大学学报,2012,26(1):63-67.

[9]GUO R,LI CP.Effects of Shugan granules on FFA,ADI,and TNFαin patients with nonalcoholic fatty liver disease[J].Chin Community Doct,2012,10(14):268-269.(in Chinese)郭睿,李昌平.舒肝颗粒对非酒精性脂肪性肝病FFA、ADI、TNF-α的影响[J].中国社区医师,2012,10(14):268-269.

[10]KASHI MR,TORRES DM,HARRISON SA.Current and emerging therapies in nonalcoholic fatty liver disease[J].Semin Liver Dis,2008,28(3):396-406.

[11]MA JM,WANG JQ.Treatment of non-alcoholic fatty liver disease from deficiency[J].J Changchun Univ Tradit Chin Med,2014,30(10):850-852.(in Chinese)马菁蔓,王景泉.从虚论治非酒精性脂肪肝[J].长春中医药大学学报,2014,30(10):850-852.

[12]LI BB,WANG L,CHEN WX,et al.Effects of curcumin on expression of liver heme oxygenase-linoon-alcoholic fatty liver dieerse rat[J].Int J Dig Dis,2013,33(6):419-421.(in Chinese)李兵兵,王龙,陈维雄,等.姜黄素对非酒精性脂肪性肝病大鼠肝组织HO-1表达的影响[J].国际消化病杂志,2013,33(6):419-421.

[13]LI J,LIU YH,LIN MT,et al.Comparison of the effects of yin chen hao decoction and gardenia on the lipid metabolism and serum enzymology in rats with non-alcohol fatty liver[J].China J Tradit Chin Med Pharma,2012,27(6):1693-1695.(in Chinese)李晶,刘益华,林曼婷,等.栀子与茵陈蒿汤对非酒精性脂肪性肝病大鼠脂质代谢及血清酶学影响的比较[J].中华中医药杂志,2012,27(6):1693-1695.

[14]PEI Q,WANG XS,LI Y,et al.Qing gan hua tan huo xue formulaon the modelo frats with nonalcoholic steato hepatitis[J].J Xinxiang Med Coll,2009,26(1):25-28.(in Chinese)裴强,王晓素,李英,等.清肝化痰活血方对非酒精性脂肪性肝炎模型大鼠的干预作用[J].新乡医学院学报,2009,26(1):25-28.

[15]YANG SJ,QIU XQ,MENG LL,et al.Influence of cigu xiaozhi pills on expressions of iN OS and eN OS in non-alcoholic fatty liver disease of rats[J].Chin Tradit Patent Med,2013,35(3):431-435.(in Chinese)杨少军,邱晓青,孟陆亮,等.慈菇消脂丸对大鼠非酒精性脂肪性肝病iN OS、eN OS表达的影响[J].中成药,2013,35(3):431-435.

[16]CHENG JM,ZHANG SS,GUO QK,et al.The effects of polydatin on insulin resistance and oxidative stress in nonalcoholic fatty liver disease[J].Chin J Interg Trad West Med Dig,2013,21(12):617-620.(in Chinese)陈剑明,张声生,郭前坤,等.虎杖苷对非酒精性脂肪性肝病胰岛素抵抗及氧化应激影响的实验研究[J].中国中西医结合消化杂志,2013,21(12):617-620.

[17]PANG Y,XU J,WANG B,et al.Effects of chailing tiaogan granule on liver tissue gene expression levels of TNF-α,LP in rats with non-alcoholic fatty liver disease[J].Chin J Integr Tradit West Med Liver Dis,2012,22(1):41-43.(in Chinese)潘洋,胥颉,王冰,等.柴苓调肝颗粒对非酒精性脂肪性肝病大鼠肝组织肿瘤坏死因子-α及瘦素基因表达的影响[J].中西医结合肝病杂志,2012,22(1):41-43.

[18]CHEN ZY,YAN MX,YE L,et al.Effect of TFHL on the expressions of PPARs in the livers of rats with nonalcoho1ic steatohepatitis[J].China J Tradit Chin Med Pharma,2012,27(1):78-81.(in Chinese)陈芝芸,严茂祥,叶蕾,等.山楂叶总黄酮对非酒精性脂肪性肝炎大鼠肝脏PPARs表达的影响[J].中华中医药杂志,2012,27(1):78-81.

[19]SALAMONE F,GALVANO F,MARINO GA.Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis[J].Dig Liver Dis,2012,41(15):334-342.

[20]XIAO TG,HE DT,JI G,et al.Effects of drug pair of ginseng and radix bupleuri on expression of FXR,SREBP-1c,and insulin resistance and leptin in rats with nonalcoholic fatty liver disease[J].Chin J Integr Tradit West Med Liver Dis,2014,24(4):234-238.(in Chinese)肖铁刚,何道同,季光,等,柴胡人参药对对非酒精性脂肪性肝病大鼠法尼醇X受体和固醇调节元件结合蛋白-1c表达的影响[J].中西医结合肝病杂志,2014,24(4):234-238.

[21]XU YJ,YANG QH,HAN L,et al.Effects of soothing liver and invigorating spleen recipes on SREBP-1c,SCD-1 mRNA and proteins expression in hepatoctes of NAFLD rats[J].J Clin Med Mater,2014,37(1):80-85.(in Chinese)徐拥建,杨钦河,韩莉,等.疏肝健脾方药对NAFLD大鼠肝细胞SREBP-1c、SCD-1 mRNA及蛋白表达的影响[J].中药材,2014,37(1):80-85.

[22]HAN L,YANG QH,ZHANG YP,et al.Intervention of berberine on lipid deposition in liver cells of non-alcoholic fatty liver disease rats induced by high fat diet[J].Chin J Integr Tradit West Med,2015,35(3):314-319.(in Chinese)韩莉,杨钦河,张玉佩,等.小檗碱对高脂饮食诱导非酒精性脂肪性肝病大鼠肝细胞脂质沉积的干预作用[J].中国中西医结合杂志,2015,35(3):314-319.

[23]JI AD,LI JX,LI L,et al.The research of adjustment of lipid metabolism factors by yi-shen-tiao-gan-recipe toward NASH rats[J].Chin Arch Tradit Chin Med,2009,27(12):2642-2644.(in Chinese)姬爱冬,李军祥,李立,等.益肾调肝方对NASH大鼠脂质代谢相关因子的调控作用研究[J].中华中医药学刊,2009,27(12):2642-2644.

[24]SERVIDDIO G,SASTRE J,BELLANTI F,et al.Mitochondrial involvement in non-alcoholic steatohepatitis[J].Mol Aspects Med,2008,29(3):22-35.

[25]ZHANG CT,ZHOU DJ,YANG H,et al.The impact of jia wei zha qu yin on FATP4,UCP2,COXI in the experimental non-alcoholic fatty liver disease rats[J].Lishizhen Med Mater Med Res,2014,25(6):1505-1507.(in Chinese)张传涛,周道杰,杨鸿,等.加味楂曲饮对实验性非酒精性脂肪性肝病大鼠FATP4、UCP2、COXⅠ的影响[J].时珍国医国药,2014,25(6):1505-1507.

[26]MA XY,GONG CJ,FU KM.Effect of ganzhixiao granule on enzyme activity correlated with lipoprotein metabolism of fatty liver rat[J].Chin J Tradit Med Sci Techno,2006,11(13):392-393.(in Chinese)马晓燕,宫成军,付克模.肝脂消颗粒剂对脂肪肝大鼠脂蛋白代谢相关酶活性影响的实验研究[J].中国中医药科技,2006,11(13):392-393.

[27]TANG CP,GUO J,YANG CY,et al.Effects of tiao zhilin capsules(TZHL)on serum LPL,HL,apoAⅠand apoB in hyperlipidemia rat modelp[J].Acad J Guangdong Pharm Coll,2007,23(2):33-37.(in Chinese)唐春萍,郭姣,杨超燕,等.调脂灵对高脂血症大鼠脂代谢酶及载脂蛋白的影响[J].广东药学院学报,2007,23(2):33-37.

[28]LI HS,FENG Q,XU LL,et al.Effects of qu shi hua yu recipe in the prevention and treatment of fatty liver in rats based on adiponectin-free fatty acid pathway[J].J Chin Integr Med,2009,7(6):546-551.(in Chinese)李红山,冯琴,许丽莉,等.祛湿化瘀方对脂肪肝大鼠"脂联素-游离脂肪酸代谢"路径的影响[J].中西医结合学报,2009,7(6):546-551.

[29]LI HS,HU YY,FENG Q,et al.Mechanism of qu shi hua yu recipe in improving the metabolism of free acid in fatty liver rats[J].J Tradit Chin Med,2010,51(3):262-264.(in Chinese)李红山,胡义扬,冯琴,等.祛湿化瘀方改善脂肪肝大鼠游离脂肪酸代谢的机制[J].中医杂志,2010,51(3):262-264.

[30]PAN JL,WANG M,JI G,et al.The efficacyand safety of traditional chinese(jiang zhi granule)for nonalcoholic fatty liver:a multicenter,randomized,placebo-controlled study[J].Evid Based Complement Alternat Med,2013,12(4):719-723.

[31]PEI Q,WANG XS,WANG XB,et al.Clinical study of qing gan hua tan huo xue recipe on the treatment of non-alcoholic steatohepatitis[J].Chin J Integr Tradit West Med,2012,32(1):30-32.(in Chinese)裴强,王晓素,王宪波,等.清肝化痰活血方治疗非酒精性脂肪性肝炎的临床研究[J].中国中西医结合杂志,2012,32(1):30-32.

[32]FENG Q,CHENG Y,HU YY,et al.Qu shi hua yu decoction inhibits ctsb protein expression and gene expression in Hep G2 cells induced by free fatty acid[J].Chin J Integr Med,2010,16(6):518-524.

[33]FENG Q,GOU XJ,HU YY,et al.Qushi huayu decoction inhibits hepatic lipid accmulation by activating AMP-activated protein kinase in vivo and in vitro[J].Evid Based Complement Alternat Med,2013,2013:14-19.

施引文献

资源附件(0)

访问统计